281 related articles for article (PubMed ID: 25780066)
21. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
Kagami S; Kaneko M; Kishi A; Katori T
J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
[TBL] [Abstract][Full Text] [Related]
22. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
Kagami S; Katori T
J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
[TBL] [Abstract][Full Text] [Related]
23. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
[TBL] [Abstract][Full Text] [Related]
24. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
25. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
27. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
28. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
29. Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin.
Okuno T; Tokuriki S; Yoshino T; Tanaka N; Ohshima Y
Pediatr Int; 2015 Apr; 57(2):e34-6. PubMed ID: 25868957
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
[TBL] [Abstract][Full Text] [Related]
31. Preliminary results of propranolol treatment for patients with infantile hemangioma.
Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
[TBL] [Abstract][Full Text] [Related]
32. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
Tan ST; Itinteang T; Leadbitter P
Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
34. Recurrence rate of infantile hemangioma after oral propranolol therapy.
Frongia G; Byeon JO; Mehrabi A; Günther P
Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
[TBL] [Abstract][Full Text] [Related]
35. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
Breur JM; de Graaf M; Breugem CC; Pasmans SG
Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
37. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature.
Nord KM; Kandel J; Lefkowitch JH; Lobritto SJ; Morel KD; North PE; Garzon MC
Pediatrics; 2006 Sep; 118(3):e907-13. PubMed ID: 16880251
[TBL] [Abstract][Full Text] [Related]
38. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
39. Current trends in medical management of infantile hemangioma.
Ames JA; Sykes JM
Curr Opin Otolaryngol Head Neck Surg; 2015 Aug; 23(4):286-91. PubMed ID: 26101875
[TBL] [Abstract][Full Text] [Related]
40. Propranolol for severe infantile hemangiomas: follow-up report.
Sans V; de la Roque ED; Berge J; Grenier N; Boralevi F; Mazereeuw-Hautier J; Lipsker D; Dupuis E; Ezzedine K; Vergnes P; Taïeb A; Léauté-Labrèze C
Pediatrics; 2009 Sep; 124(3):e423-31. PubMed ID: 19706583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
